Biomarin Pharmaceutical Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biomarin Pharmaceutical Inc with three other
companies in this sector in the United States:
United Therapeutics Corporation
sales of $1.63 billion
of which 37%
Amneal Pharmaceuticals Inc
of which 87%
was Generics), and
Horizon Therapeutics PLC
of which 21%
was K R Y S T E X X A).
Biomarin Pharmaceutical Inc reported sales of $1.49 billion
December of 2018.
increase of 13.5%
versus 2017, when the company's sales were $1.31 billion.
Sales at Biomarin Pharmaceutical Inc have increased during each of the previous five years
(and since 2013, sales have increased a total of 172%).